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Summary 
 
Laminitis has many triggers and comparing the histopathology of lesions induced by 
different causes may help to establish whether a common mechanism or multiple 
pathologies are involved.  The aim of this study was to describe the microscopical 
lesions and to quantify morphometric changes in the lamellae of horses with insulin-
induced (n = 4) and oligofructose-induced laminitis (n = 4) compared with normal 
controls (n = 4).  Archived lamellar samples collected during two previous studies 
were used.  Laminitis was induced within 48 h in standardbred horses with either a 
euglycaemic, hyperinsulinaemic clamp (EHC) technique, or in a separate experiment, 
with an overdose of alimentary oligofructose (OF).  Normal tissue was obtained from 
control horses in the EHC experiment that received a balanced electrolyte solution 
intravenously for 48 h.  Six measurements of lamellar length and width were recorded 
for each hoof.  Leucocyte infiltration was assessed by immunolocalisation of 
calprotectin.  All control horses exhibited normal lamellar architecture, whereas 
treated horses developed clinical and histopathological changes consistent with 
laminitis.  Laminitic samples displayed lengthening and narrowing of secondary 
epidermal lamellae (SELs), rounded epidermal basal cell nuclei, mitosis and apoptosis. 
In the fore feet of laminitic horses, the length from the end of the keratinised axis to 
the axial tip of the primary epidermal lamellae (PELs) was increased (P < 0.05). SELs 
were significantly longer (P < 0.05) and narrower (P < 0.05) in the treated horses 
compared with controls. The two treated groups did not differ from each other in SEL 
length or width.  Calprotectin expression was absent in control horses, moderate in 
hyperinsulinaemic horses and marked in oligofructose-treated horses.  Laminitis 
induced experimentally with insulin or oligofructose results in comparable 
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lengthening and narrowing of the SELs and elongation of the axial end of the PELs at 
48 h.  Immunolocalization of calprotectin indicated that hyperinsulinaemia induces 
less leucocyte emigration than carbohydrate overload at 48 h.  The microscopical 
lesion of laminitis is similar, but not identical in different forms of the disease.  
 
Keywords: hyperinsulinaemia; histology; epidermal lamellae; calprotectin 
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Introduction 
 
Risk factors for equine laminitis are diverse, and can be associated with 
alimentary carbohydrate overload (ACO), sepsis, inflammation and endocrine disease.  
The clinical outcome of lameness may be the same, but the underlying pathogenesis 
of the lamellar damage is incompletely understood.  Whether different causes of 
laminitis ultimately trigger a common pathophysiological mechanism, despite 
resulting from disparate pathways, is also unclear.  Scientists have long sought to 
better describe the pathophysiological processes occurring within lamellar structures 
in the prodromal and acute stages of this unique disease, but progress has been slow.  
Experimental models allow analysis of the acute stages of laminitis and relate to the 
risk factors listed above.  Extract of black walnut (BWE) is said to mimic systemic 
inflammatory response syndrome (SIRS), (Galey et al., 1991; Belknap et al., 2009; 
Eades, 2010) while ACO with starch (Garner et al., 1975) or oligofructose (OF) (van 
Eps and Pollitt, 2006) simulates SIRS secondary to colitis.  More recently, the use of a 
prolonged euglycaemic, hyperinsulinaemic clamp (EHC) (Asplin et al., 2007) has 
provided a way to model hyperinsulinaemic laminitis (the insulin-induction model), 
which occurs without clinical evidence of systemic illness or inflammation.  
 
Histological descriptions of experimentally-induced laminitis (Pollitt, 1996; 
Morgan et al., 2003; Faleiros et al., 2004;  van Eps and Pollitt, 2009; Asplin et al., 
2010) have defined features of the laminitis lesion and have enhanced appreciation of 
the pathophysiological processes involved.  Conversely, histological accounts of 
naturally-occurring laminitis are scant (Roberts et al., 1980; Ekfalck et al., 1992).  An 
accurate description of various types of experimentally induced and naturally-
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occurring cases of laminitis is important in order to understand the disease more fully. 
Reports include histological descriptions (Pollitt, 1996; Morgan et al., 2003), 
assessment of the degree of apoptosis (Faleiros et al., 2004) and leucocytic infiltration 
using calprotectin immunohistochemistry (Visser, 2008; Faleiros et al., 2009). 
Calprotectin is a calcium binding protein complex that can be found in the cytoplasm 
of neutrophils and on the membrane of monocytes (Striz and Trebichavsky, 2004). 
Calprotectin expression by keratinocytes is increased in human inflammatory 
dermatoses (Kelly et al., 1989). 
 
Endocrinopathic and pasture-associated forms of laminitis occur commonly 
(USDA, 2000; Geor, 2009).  The unifying factor in endocrinopathic (including equine 
metabolic syndrome) and pasture-associated laminitis is hyperinsulinaemia (Treiber et 
al., 2006; McGowan, 2008).  Understanding how excess insulin damages lamellar 
integrity may enhance the ability to prevent laminitis.  The present study describes the 
acute laminitis lesions of prolonged hyperinsulinaemia and compares them with those 
induced by dosing with OF in standardbred horses of a similar bodyweight.  This is 
the first study to describe the lesions of insulin-induced laminitis in detail in horses 
and the first direct histological comparison between the ACO and EHC models of 
laminitis.  The differences were quantified by primary epidermal lamellar (PEL) and 
secondary epidermal lamellar (SEL) morphometry and the presence of lamellar 
leucocytes was confirmed with calprotectin immunohistochemistry (IHC). 
 
Materials and Methods 
 
Horses 
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Archived lamellar samples from two previous experiments were used in this 
study (van Eps and Pollitt, 2006; de Laat et al., 2010).  In one experiment, laminitis 
was induced within 48 h in four healthy standardbred horses (427 ± 34 kg), aged 5.8 ± 
1.3 years, using a continuous infusion of insulin (Humulin-RTM; Eli-Lily Australia, 
West Ryde, New South Wales, Australia) at a rate of 6 mIU/kg bwt/min, with glucose 
(50 % dextrose; Baxter Healthcare, New South Wales, Australia) administered 
concurrently at a variable infusion rate to maintain euglycaemia.  Each treated horse 
was paired with a matched control standardbred horse (432 ± 14 kg; 5.1 ± 0.7 years) 
that received a balanced electrolyte solution at a rate of 0.57 ml/kg bwt/hr for the 
same period under identical conditions (de Laat et al., 2010).   
 
Laminitis was induced in a separate experiment in healthy standardbred horses 
(n = 6) after dosing with OF (Raftilose P-95; Orafti Active Food Ingredients, Tienen, 
Belgium) at a rate of 10 g/kg bwt (dissolved in 4 l water and administered via 
nasogastric tube), and four of these horses (451 ± 7.9 kg; 7.0 ± 1.8 years) were 
selected randomly for this study (van Eps and Pollitt, 2006).  Mean ± SE serum 
insulin concentration at the conclusion of the experiment was higher in the insulin-
treated horses (1179 ± 228 µIU/ml) when compared with the OF-treated (16.2 ± 2.3 
µIU/ml) and control horses (10.6 ± 1.2 µIU/ml).   
 
All horses had normal radiographic anatomy and no evidence of lameness or 
hoof abnormalities on clinical inspection, prior to the experiments.  Clinical signs of 
lameness began at 31.5 ± 4.65 h in the insulin-treated horses and 28 ± 1.83 h in OF-
treated horses.  Horses were humanely destroyed at the onset of grade 2 Obel (Obel, 
1948) lameness (insulin group; 46 ± 2.3 h) or at 48 h (OF and control groups).  The 
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Obel grade of laminitis for the OF group was 2.5 ± 0.3 (two horses grade 2 and two 
horses grade 3).  The control horses did not display any clinical signs of lameness. 
 
Ethical approval for this work was granted by the animal ethics committee of 
The University of Queensland (SVS/108/09/RIRDC) which ensures compliance with 
the Animal Welfare Act of Queensland (2001) and the Australian Code of Practice for 
the Care and Use of Animals for Scientific Purposes (7th Edition, 2004). The horses 
were monitored continuously by a registered veterinarian. 
 
Sample Processing  
Full thickness lamellar specimens (5 × 5 mm) were placed immediately in 
10% neutral buffered formalin for 24 h before being processed routinely.  Following 
embedding in paraffin wax, lamellar specimens were sectioned (5 µm), mounted on 
Superfrost PlusTM slides (Menzel, Braunschweig, Germany)  and either left unstained 
for IHC or stained with haematoxylin and eosin (H&E) or periodic acid–Schiff (PAS) 
for light microscopy. 
 
Histological Analysis  
H&E and PAS stained sections from all four feet of all horses were 
randomized and examined via light microscopy (Olympus BX-50; Olympus 
Corporation Lifesciences, Japan) by one of the authors experienced in describing 
lamellar histopathology (CCP), who was blinded to the group of origin.  
Randomization of all sections was then repeated prior to measurement of the primary 
and secondary epidermal lamellae by a different author (MAD) according to the 
following protocol.  Six sets of measurements were made on each section using image 
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analysis software (ImagePro; Media Cybernetics Inc, Bethesda, MD): total primary 
epidermal lamellar length (TPELL), keratinised primary epidermal lamellar length 
(KPELL), length of the axial tip of the PEL, SEL length of SELs located at the base 
(abaxial, SELLB) and tip (axial, SELLT) of each selected PEL, and SEL width in the 
mid-section of the PEL (SELW).  Two of these parameters (axial tip length and SEL 
width) have not, to our knowledge, been measured before.  Eight PEL were measured 
twice for each hoof at ×20 magnification to determine KPELL and TPELL.   
 
Measurement of each PEL (Fig. 1a) was made in a straight line from the tip of 
the adjacent primary dermal lamella (PDL) to the end of the keratinised axis (KPELL) 
or the middle of the tip (TPELL). The difference between the TPELL and KPELL was 
then calculated in order to quantify the length of the axial end of the PELs in each 
horse (Fig. 2).  The length of ten, randomly-selected SELs was measured at ×100 
magnification in both the lower (abaxial; 10–30%) and upper (axial; 70–90%) third of 
each selected PEL (Fig. 1b). The width of twenty SELs was measured at ×200 
magnification in the middle section (30–70%) of each PEL (Fig. 1b).  In order to 
ensure the integrity of the measurement protocol, 50% of the sections were selected at 
random and measured again, according to the above protocol, by a blinded 
independent party.  These measurements were not included in the results, but were 
used solely to internally validate the measurement protocol. 
 
Immunohistochemistry 
IHC was performed using the EnVision+ System-HRP (Dako, Carpinteria, 
California) according to the manufacturer’s instructions.  Antigen retrieval was 
performed using 0.05% proteinase K ready-to-use solution (Dako) for 6 min at room 
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temperature. Monoclonal mouse anti-human macrophage antibody (MAC-387; Dako) 
was diluted 1 in 400 in antibody dilution solution with background reducing 
components (Dako). Mouse IgG was used in place of the primary antibody for a 
negative control.  Positive control tissue was taken from a horse with ACO laminitis 
(Visser, 2008).  Slides were incubated with the chromogen 3, 3’-diaminobenzidine 
tetrahydrochloride (DAB; Dako) for 8 min and counterstained with Mayer’s 
haematoxylin for 1 min.  
 
Grading of Calprotectin Expression 
Immunoreactivity for calprotectin was analysed in samples from all feet, in 
blinded fashion by one of the authors (CCP).  The degree of calprotectin expression in 
the lamellae of each hoof was graded using the following scale: 0, no labelling or 
occasional calprotectin-positive cells within vessel walls; 1, mild perivascular 
infiltration of labelled cells into primary dermal lamellar tissue; 2, moderate, diffuse 
infiltration of labelled cells throughout the dermal connective tissue; 3, marked tissue 
infiltration of labelled cells with positive labelling of the SEL basal and parabasal cell 
cytoplasm. 
 
Statistical Analyses  
Within each group, epidermal lamellar measurements for both fore feet were 
averaged and compared with the average measurement for the hind feet, using a 
Welch t-test. Epidermal measurements of both fore feet were compared between 
groups using two-way analysis of variance (ANOVA), with horse number and group 
used as the two class variables to account for clustering.  Pair-wise comparison of 
means was assessed with Tukey’s honestly significant difference test.  Within groups, 
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average fore foot SELL was compared between axial and abaxial locations using a t-
test.  The level of agreement between observers was assessed with Bland-Altman’s 
limits of agreement (LOA) and Lin’s concordance co-efficient (ρc) where both co-
variation and correspondence are used as a measure of reliability.  Pearson’s 
correlation coefficient was used to assess the random variation of inter-rater 
agreement.  Median scores for tissue immunoreactivity to calprotectin for each horse 
were compared between groups using a Kruskal-Wallis one-way ANOVA on ranks.  
Median fore and hind foot calprotectin score was compared within each group using a 
Wilcoxon test.  All data are presented as mean ± SE or median (interquartile range).  
Statistical significance was set at P < 0.05.  Statistical analyses were performed using 
R version 7.2.7 (R Foundation for Statistical Computing, Vienna, Austria). 
 
Results 
 
Lamellar Histology  
 
Control Horses:  All of the control horses exhibited normal lamellar architecture in 
sections from all four feet (Figs. 1a–c).  Microscopical descriptions of normal equine 
lamellae have been published previously (Pollitt, 1994; Pollitt, 2004; Asplin et al., 
2010) and the lamellae from the control horses in the current study were consistent 
with these descriptions.  Descriptive histology was similar between the fore and hind 
feet of all control horses. 
 
Insulin-Induced Laminitis:  All hyperinsulinaemic horses developed laminitis within 
the 48 h period, with three out of four horses developing laminitis in all four feet.  The 
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lamellae appeared normal in the right hind foot of the horse with the lowest 
bodyweight, but laminitis lesions were present in the other three feet (de Laat et al., 
2010).  The PEL of the hyperinsulinaemic horses showed varying degrees of 
dyskeratosis (abnormal, premature or imperfect keratinization of EBCs), particularly 
in the axial regions.  Disorganization of SELs was widespread throughout the abaxial, 
mid and axial regions of the PEL.  The SEL appeared lengthened with sharp, pointed 
tips and a loss of symmetrical angulation to the PEL axis.  Many SELs were wider at 
the base, tapering toward the tip, while some were uniformly narrowed and had 
become either undulant or crescent shaped (Figs. 1d, e).  Clear demarcation of 
individual SELs at the PEL axis was lost; with secondary epidermal basal cells 
becoming confluent (Fig. 1e).  Many epidermal cell nuclei appeared rounded, with 
prominent and often multiple nucleoli and many had lost their apical position in the 
EBC cytoplasm.  Apoptotic EBCs and mitotic figures occurred more frequently than 
in control sections and were seen throughout the axial and mid-sections of the PEL 
(Fig. 1d inset).  Pathological changes tended to be more severe at the axial tips of the 
PELs, adjacent to the distal phalanx (Fig. 1f).  SELs in this region were often severely 
disorganized and many were devoid of basal cells, yet still outlined by PAS positive 
BM (Fig. 1f).  Empty teat-shaped profiles of PAS positive BM, no longer adherent to 
EBCs, were present at the tips of attenuated SELs (Fig. 1f inset).  This BM 
dysadhesion from EBCs, and patchy loss of PAS positive BM staining, occurred in 
the front feet of all horses, but only rarely in hindlimb sections.   BM compromise 
varied in severity between individuals, from showing occasional, mild loss of BM 
integrity at the tips of axially located SELs in the least affected horse, to BM changes 
affecting many SELs along the length of the PEL, in the front feet of the two most 
severely affected horses.  The endothelial cells of SDL capillaries were swollen and 
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protruded into the lumina of vessels.  Red blood cells had extravasated into many 
SDLs and leucocytes were present both within blood vessels and in the connective 
tissue surrounding them.   Infiltrating leucocytes were common in the dermal tissue 
around the tips of the PELs and some had penetrated SELs empty of EBCs (Fig. 1f). 
In general, the laminitis lesions were similar in both the fore and hindlimbs of all 
horses; however, severity was greater in the fore feet. 
 
Oligofructose-Induced Laminitis:  Laminitis histopathology of the OF-treated horses 
showed many similarities to the wheat starch overload model (Pollitt, 1996) and the 
hyperinsulinaemic horses.  Marked attenuation of the SELs along the length of the 
PEL was accompanied by cellular changes including increased mitosis, apoptosis and 
rounding of EBC nuclei.  There was evidence of BM detachment and disintegration 
along the length of the SELs, especially at the base of the SEL adjacent to the PEL 
axis, and of the SEL tips in the axial region of the PELs, in all of the OF-treated 
horses (Fig. 2b).  BM damage appeared to be more widespread and severe in the OF-
treated horses than in the hyperinsulinaemic horses, comparable with the wheat starch 
model (Pollitt, 1996). 
 
Morphometry  
Overall, the level of agreement between the two observers for both the PEL 
and SEL measurements was high (Table 1).  Total and keratinized PELL were 
increased in forelimb hooves compared with the hindlimb hooves (P < 0.05), in the 
insulin-treated group (Table 2).  SEL measurements were not different between the 
fore and hind feet (Table 2).  As this is the first detailed morphological study of 
insulin-induced laminitis to include the hind feet, in order to allow accurate 
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comparison with previous studies, PEL and SEL measurements were compared 
between the three groups using the forelimbs only. Neither total nor keratinised PELL 
differed between any of the groups (Table 2); however, the distance from the end of 
the keratinised axis to the axial tip of the PELs was increased in laminitic horses 
compared with control horses (Fig. 2).  SEL length was increased (P < 0.05) abaxially 
and axially on the PEL, in both the insulin- and OF-treated groups, when compared 
with the control group (Table 2).  SEL length did not differ between the laminitic 
groups at either location (Fig. 3).  Axial SEL length was not different to abaxial SEL 
length in any group. Although the SEL were wider (P < 0.05) in the control group 
compared with both laminitis groups (Table 2), the width of the SEL did not differ 
between the two treated groups. 
 
Calprotectin Expression  
Immunolocalization of calprotectin in control horses was limited to an 
occasional leucocyte confined within venules in the dermal connective tissue (grade 0; 
Fig. 4a), in both fore and hind feet.  In the insulin-treated group there was an increase 
in the number of calprotectin-positive cells (identified as neutrophils and monocytes 
on HE-stained sections) located around vessels in the primary dermal lamellae and in 
the lamellar dermis, around the tips of each PEL (grade 1; range 0.6 - 1.0; Fig. 4b).  
The lamellar EBC cytoplasm also showed occasional, mild, positive expression of 
calprotectin at the tips of SELs located at the axial tip of the PEL.  Calprotectin-
positive cells were also located within the lamellar BM (Fig. 4b).  The expression of 
calprotectin was stronger (P < 0.05) in fore foot sections (grade 1.8; range 1–2) when 
compared with the hind feet (grade 0; range 0–0.3) in the insulin-treated horses, with 
most of the hindlimb sections showing little to no calprotectin expression.  The OF-
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induced laminitis group showed diffuse, heavy calprotectin labelling in both the 
lamellar epidermal basal cells, predominantly in the axial third of the PEL, and cells 
in the dermis surrounding the tips of the PEL (grade 3; range 2.9–3.0; Fig. 4c), with 
stronger calprotectin expression than both the control and insulin-treated horses (P < 
0.05).  Strong expression of calprotectin was seen in both the cytoplasm and the 
nuclei of the lamellar epidermal basal cells (Fig. 4c).  Both the fore and hind feet were 
affected equally in the OF-treated horses (grade 3 [range 3–3] and grade 3 [2.8 – 3], 
respectively). 
 
Discussion 
 
The histological features of different types and stages of laminitis have been 
described previously (Pollitt, 1996; Morgan et al., 2003; French and Pollitt, 2004; 
Visser, 2008;  van Eps and Pollitt, 2009; Asplin et al., 2010).  The results of the 
present study add to this field of knowledge by describing lesions resulting from 
insulin-induced laminitis in standardbred horses for the first time, and by comparing 
lamellar morphometry and calprotectin immunoreactivity 48 h after the induction of 
laminitis with hyperinsulinaemia and OF.  
 
The measurement protocol was similar to that used by Asplin et al. (2010) 
who described lesions in ponies with insulin-induced laminitis.  Despite the different 
time points examined (46 versus 55 h), the similarities in experimental design and the 
Obel grade of laminitis examined should allow reasonable comparisons with the 
current study.  Many histopathological features of insulin-induced laminitis were 
similar in horses and ponies; however, the degree of BM damage was more extensive 
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in horses than reported in ponies.  Significant elongation of SELs was a consistent 
finding in both horses and ponies with insulin-induced laminitis and in horses with 
OF-induced laminitis, when compared with normal horses.  Separation of the BM was 
variable between ponies treated with insulin, and when it did occur, was confined to 
SELs at the axial tips of the PEL (Asplin et al., 2010).  In the current study, BM 
disintegration and dysadhesion in SELs ranged from mild to extensive, but was 
present in all insulin-treated horses, appeared more widespread and involved a greater 
proportion of SELs.  This increased degree of BM pathology may be due to the 
greater bodyweight of horses exerting more strain on the lamellae, compared with 
ponies.  The difference was not associated with the Obel grade of lameness since both 
horses and ponies were only treated until the onset of Obel grade 2 lameness. 
However, in insulin-treated horses the degree of clinical severity did differ marginally 
within this grade.  Indeed, the horses that exhibited more frequent shifting of 
bodyweight in the current study also exhibited more severe BM disruption.  The 
finding of BM separation in this study is consistent with previous descriptions of 
laminitis in horses associated with ACO and systemic inflammation, albeit to varying 
degrees (Pollitt, 1996; Morgan et al., 2003; French and Pollitt, 2004; Bailey et al., 
2009).  Further studies have shown that enzymatic processes, such as unregulated 
metalloproteinase activity, are unlikely to be an inciting cause of BM disruption in 
insulin-induced laminitis (de Laat et al., 2011), while they have been associated with 
BM dysadhesion in OF-induced laminitis (Kyaw-Tanner et al., 2008). This may 
suggest that physical disruption of the BM, rather than enzymatic destruction, is a 
feature of hyperinsulinaemic laminitis, however further studies to investigate this 
theory are required.  Variably increased numbers of mitotic figures and apoptotic cells 
in the lamellar epidermis were a feature of insulin-induced laminitis, both in this study 
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and in ponies (Asplin et al., 2010).  Increased mitosis is potentially due to 
hyperinsulinaemia causing over-stimulation of the intracellular mitogen-activated 
protein kinase signalling pathway, which is responsible for cell proliferation (Cusi et 
al., 2000).  However, the finding also occurs in other forms of laminitis (Pollitt, 1996; 
Faleiros et al., 2004) and may reflect general reparative processes. 
 
By including all four feet from each horse, this study allowed direct 
comparison of fore and hindlimb lamellar pathology, including quantification of 
SELL and PELL and the degree of leucocyte infiltration during laminitis.  Total PELL 
was greater in the fore feet compared with the hind feet in insulin-treated horses, but 
not in the OF-dosed or control group, although it is likely that failure to achieve 
statistical significance in the latter two groups was a consequence of the small sample 
size, considering the strong trend towards increased fore foot PELL in all groups. Fore 
and hind foot lamellar histopathological scores have been compared previously in OF-
induced laminitis (van Eps and Pollitt, 2006), where it was found that the histological 
score given to the front feet was always equal to, or more severe than, the hind feet of 
the same horse.  The observation that lesions tended to be more severe in the fore feet 
in the current study may be related to weight bearing.  It has been documented that 
horses bear up to 60% of their body weight on their front feet compared with 40% on 
their hind feet (Hood, 1999).  A larger sample size would be necessary to determine if 
this finding is applicable to the wider population.  Due to the fact that PELL was not 
the same for fore and hind foot measurements, and to conform to previous studies, 
only fore foot data were used when comparing morphometry between the groups. 
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PELL was not increased at the 48 h time point in insulin-induced or OF-
induced laminitis, which is in agreement with insulin-induced laminitis in ponies 
(Asplin et al., 2010).  However, the length of the axial end of the PELs was increased 
in both the OF and insulin-treated horses compared with the control group, reflecting 
the severity of the lesions (BM dysadhesion and SEL disorganization) in this location. 
When TPELL was measured 7 days after OF dosing, a significant difference was 
recorded between control and OF-treated horses, indicating that an increase in TPELL 
may occur at later time-points (van Eps and Pollitt, 2009).  Cellular proliferation and 
attempts at tissue repair at the tips of the PEL, especially around areas of detached 
BM, may account for this overall increase in TPELL in chronic disease.  
 
The finding of significantly elongated SEL at both the base (abaxial) and tip 
(axial) of the PEL in both groups of treated horses, confirms previous descriptions of 
laminitis (French and Pollitt, 2004; de Laat et al., 2010) and supports the findings of 
Asplin et al. (2010) in ponies.  An important finding here is that SEL length was 
similar in both the insulin and OF models of laminitis at 48 h, both axially and 
abaxially, despite quite marked differences in leucocyte recruitment demonstrated 
using calprotectin.  It remains to be determined whether structural or cellular changes 
are more important in determining the clinical severity of laminitis, but at least 
structurally, the lesions produced by the two experimental models did not differ 
greatly in severity from each other at 48 h.  Whether this similarity in SEL length 
would persist at higher grades of laminitis, or at later time-points in the disease, is 
unknown.  
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To our knowledge, the current study is the first to measure SEL width in any 
form of laminitis.  The width of the SEL in the middle section of the PEL was 
substantially reduced in both hyperinsulinaemic (1.9 fold) and OF-induced (1.7 fold) 
horses compared with normal controls.  This finding also confirms previous 
descriptive reports of insulin-induced (de Laat et al., 2010) and OF-induced (French 
and Pollitt, 2004) laminitis in horses.  This reduction in SEL width may be 
attributable to changes in shape of the epidermal basal cells and may also result from 
the general disorganization of SELs in laminitic horses.  Temporal information from 
the developmental stages of insulin-induced laminitis will add to this field of 
knowledge.  Histological analysis of chronic cases of pasture-associated laminitis will 
also be important in investigating the nature of the hyperinsulinaemic lamellar lesion. 
 
The lack of calprotectin expression in the lamellae of control horses is 
consistent with findings in other studies where lamellar sections from normal or 
control horses show little or no calprotectin labelling (Visser, 2008; Faleiros et al., 
2009).  This finding is also in agreement with studies showing little or no calprotectin 
expression in the normal, human integument (Kelly et al., 1989).  Stronger expression 
of calprotectin in the fore feet of the insulin-induced horses, when compared with 
hind feet, is consistent with our earlier observation that lesions tended to be more 
severe in the front feet.  A comparison between the insulin- and OF-induced models 
shows much stronger and more widespread calprotectin immunolocalization in the OF 
group. This difference in calprotectin immunoreactivity, up to 48 h, is possibly 
associated with the severity of the laminitis (insulin; Obel grade 2 versus OF; Obel 
grade 2.5) or may indicate a difference in the type of lamellar lesion between the 
experimental models.  OF-induced laminitis appears to produce a more inflammatory 
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lesion, similar to BWE-induced laminitis that has been likened to SIRS in man 
(Faleiros et al., 2009).  Indeed, both the BWE and OF methods of laminitis induction 
are associated with signs of systemic illness such as depression or anorexia (Galey et 
al., 1991) and diarrhoea and fever (van Eps and Pollitt, 2006).  An inflammatory 
response has also been detected in affected lamellae (Belknap et al., 2007; Leise et al., 
2011).  In contrast, laminitis caused by the insulin-induction model does not result in 
systemic illness (de Laat et al., 2010), indicating that hyperinsulinaemia may be less 
inflammatory than either OF or BWE, and result in less lamellar inflammation, as 
suggested by the subdued calprotectin response in the current study.  Studies on early 
and developmental stages of BWE laminitis have shown a significant increase in 
calprotectin-positive cells (Faleiros et al., 2009) and CD163-positive macrophages 
(Faleiros et al., 2011) in lamellar tissue as early as 1.5 h post induction.  This differs 
considerably to the findings of a temporal study of OF-induced laminitis, where 
calprotectin expression was first detected between 18 and 30 h post induction (Visser, 
2008).  The authors of the BWE studies postulated that leucocyte infiltration played a 
developmental role in the BWE-induced lamellar lesion.  However, findings from the 
temporal OF study showed that leucocyte infiltration occurred after changes in BM 
pathology were underway, thus downplaying an early pathogenic role for leucocytes. 
A study of calprotectin immunolocalization at earlier time-points in 
hyperinsulinaemic horses would help to demonstrate the temporal pattern of leucocyte 
invasion in this type of laminitis.  
 
Overall, the findings of this study contribute to the current available data on 
the lamellar damage sustained by insulin-treated horses, and provide the first direct 
histological comparison between the insulin- and OF-induced models of laminitis. 
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While there are major similarities between the lamellar lesions seen in the two groups, 
such as the extent of lengthening and narrowing of the SEL and the occurrence of BM 
damage, mitosis and apoptosis, there are also differences.  The degree of calprotectin 
expression is more marked and widespread in the OF-induced model, which may 
suggest a greater role for inflammation in the lamellae of these horses when compared 
with the hyperinsulinaemic horses.  Examining the histopathology of insulin-induced 
laminitis and comparing it to other forms of the disease may facilitate improved 
understanding in this complex field of research and allow the development of 
appropriate treatment strategies in the future. 
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 Tables 
 
Table 1: Agreement between two observers who each measured all of the parameters  
 
Statistical test TPELL KPELL SELLB SELLT SELW 
Concordance (Lin’s ρc) 0.94 0.89 0.80 0.92 0.84 
(Lower 95% CI) (0.92) (0.86) (0.77) (0.90) (0.81) 
Pearson’s r 0.94 0.90 0.81 0.92 0.84 
(95% CI) (0.92, 
0.96) 
(0.85, 
0.93) 
(0.76, 
0.84) 
(0.90, 
0.93) 
(0.80, 
0.87) 
Bland Altman (LOA) 15.4 µm 10.4 µm 3.75 µm 2.00 µm 0.27 µm 
(lower and upper 
confidence limit) 
(-134,165) (-174,194) (-67, 74) (-70, 74) (-7.8, 8.4) 
% between 95% CI 93% 93.7% 89.5% 91.2% 95.6% 
 
Agreement was determined with Bland-Altman’s limits of agreement (LOA) and Lin’s concordance 
co-efficient (ρc).  Pearson’s correlation coefficient was used to assess the random variation of inter-
rater agreement (r [95% CI]).  The percentage of measurements that fell between the 95% confidence 
intervals (CI) was also measured for each parameter.  Overall, there was excellent agreement between 
the two observers.  TPELL, total primary epidermal lamellar length; KPELL, keratinised primary 
epidermal lamellar length; SELLB, length of the secondary epidermal lamellae at the abaxial end of the 
PEL; SELLT, length of the secondary epidermal lamellae at the axial end of the PEL; SELW, 
secondary epidermal lamellar width at the midpoint of the PEL. 
 
 
 
Table 2: Mean epidermal lamellar lengths 
 
Length (µm) TPELL KPELL SELLB* SELLT* SELW* 
Control       
  fore 3335 ± 194 2965 ± 146 140 ± 19* 116 ± 23* 25 ± 2.5* 
  hind 2826 ± 195 2654 ± 235 137 ± 14 121 ± 6.5 23 ± 1.7 
Insulin      
  fore 3367 ± 54 † 2746 ± 59† 234 ± 14 256 ± 45 13 ± 1.5 
  hind 2708 ± 58 2226 ± 44 201 ± 18 216 ± 11 17 ± 3.3 
Carbohydrate      
  fore 3334 ± 187 2764 ± 178 237 ± 14 251 ± 27 15 ± 2.2 
  hind 2829 ± 204 2422 ± 138 229 ± 26 195 ± 18 17 ± 1.5 
 
Mean ± SE epidermal lamellar lengths (µm) of three groups of horses (n = 4) were measured after 48 h 
of treatment with either a balanced electrolyte solution (control), a combined insulin and glucose 
infusion (insulin) or oral oligofructose (carbohydrate). Measurements were made in all four feet of each 
horse.  Eight primary epidermal lamellae (PEL) were measured twice and total and keratinized lengths 
recorded.  The length of ten secondary epidermal lamellae (SEL) was measured at both the base and tip 
of all eight PEL.  The width of twenty SEL was measured in the mid-section of each PEL.  TPELL, 
total primary epidermal lamellar length; KPELL, keratinised primary epidermal lamellar length; 
SELLB, length of the secondary epidermal lamellae at the abaxial end of the PEL; SELLT, length of 
the secondary epidermal lamellae at the axial end of the PEL; SELW, secondary epidermal lamellar 
width at the midpoint of the PEL.  The asterisk denotes whether the forelimb measurements differ (P < 
0.05) between the three groups for each parameter using two-way analysis of variance and Tukey’s test.  
The † indicates if the forelimbs differ (P < 0.05) to the hindlimbs for each parameter within each group 
using a Welch t-test. 
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Figures 
 
Fig. 1:  Photomicrographs of hoof lamellar histology from control (a–c) and insulin-
treated (d–f) standardbred horses in transverse section.  Lamellar measurements (a, b) 
included the total (A) and keratinized (B) length of the primary epidermal lamellae 
(PEL) and the length (C) and width (D) of the secondary epidermal lamellae (SEL).  
In control horses the PEL were straight and uniform in length, with the keratinized 
axis finishing before the PEL axis (a).  The SEL were uniform in length and clearly 
separated by each secondary dermal lamella (SDL), which extended almost to the 
PEL axis (b, c).  Epidermal basal cell (EBC) nuclei (white arrowheads in b) were 
ovoid and located apically in the cell and the PAS stained basement membrane (BM) 
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was tightly adherent to the rounded tips of each SEL and continued intact to within 
one or two EBCs of the PEL axis (black arrows in c).  The microvasculature 
surrounding the SEL appeared normal (white arrows in b and c).  In insulin-treated 
horses the SEL appeared lengthened with sharp, pointed tips (d, e) and the EBC nuclei 
were variable in size and rounded with prominent, and often multiple, nucleoli (white 
arrowheads in d and e).  Clear demarcation of individual SEL at the PEL axis was lost 
(asterisk in c).  Pyknotic (black arrowhead in d inset) and mitotic (black arrow in d 
inset) figures were present.  Loss of PAS positive BM staining was apparent (black 
arrows in e and f) with empty profiles of BM (white arrows in f) and a lack of visible 
BM at SEL bases (e).  The microvasculature appeared more prominent (white arrow 
in d and white arrowhead in f) when compared with control sections (white arrows in 
b and c).  H&E (a, b, d) and PAS (c, e, f). 
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Fig. 2:  Photomicrographs of hoof lamellar histology at the axial end of PELs from (a) 
control, (b) oligofructose and (c) insulin-treated standardbred horses in transverse 
section.  The average length from the end of the keratinized axis of the PEL to the 
axial tip of the PEL was shorter (P < 0.05) in control horses (328 ± 46 µm) when 
compared with horses with oligofructose (485 ± 54 µm) and insulin-induced (469 ± 
29 µm) laminitis.  H&E. 
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Fig. 3:  Mean ± SE secondary epidermal lamellar (SEL) length (µm) was measured at 
the base and the tip of the primary epidermal lamellae (PEL) in three groups of horses 
(n = 4) 48 h after treatment with a balanced electrolyte solution (█), a combined 
insulin and glucose infusion (▒) or oral oligofructose (▓).  SEL length was longer (P 
< 0.05) at both the base and tip in both insulin and oligofructose treated horses when 
compared with the control horses.  The two treated groups did not differ from each 
other. 
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Fig. 4:  Photomicrographs of hoof lamellae labelled for calprotectin expression in (a) 
control, (b) insulin-treated and (c) oligofructose-treated standardbred horses in 
transverse section.  (a) Immunolocalization of calprotectin in control horses was 
largely non-existent.  (b) In insulin-treated horses, there was an increase in the number 
of calprotectin-positive cells in the lamellar dermis and around the tips of each PEL 
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(white arrowheads) with a few cells appearing to be within the lamellar BM (black 
arrowheads).  (c) In oligofructose-treated horses, calprotectin immunoreactivity was 
marked, with labelling of cells in the lamellar dermis (white arrowheads) as well as 
apparent nuclear (black arrowheads) and cytoplasmic (yellow arrowheads) 
involvement of epidermal cells.  IHC. 
